Guardant Health Shares Outstanding 2017-2022 | GH

Guardant Health shares outstanding from 2017 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Guardant Health Annual Shares Outstanding
(Millions of Shares)
2021 101
2020 98
2019 91
2018 30
2017 13
2016 13
Guardant Health Quarterly Shares Outstanding
(Millions of Shares)
2022-03-31 102
2021-12-31 101
2021-09-30 101
2021-06-30 101
2021-03-31 101
2020-12-31 98
2020-09-30 100
2020-06-30 96
2020-03-31 94
2019-12-31 91
2019-09-30 93
2019-06-30 89
2019-03-31 86
2018-12-31 30
2018-09-30 13
2018-06-30 12
2018-03-31 12
2017-12-31
2017-09-30 12
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.799B $0.374B
Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant Health Inc. is based in REDWOOD CITY, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $164.215B 9.99
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.343B 16.33
Biohaven Pharmaceutical Holding (BHVN) United States $10.057B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.540B 0.00
Emergent Biosolutions (EBS) United States $1.675B 7.17
Arcus Biosciences (RCUS) United States $1.287B 32.64
Myovant Sciences (MYOV) United Kingdom $0.927B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.347B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.113B 23.10
SQZ Biotechnologies (SQZ) United States $0.094B 0.00